Inactive Instrument

NOVAGALI PHARMA Share Price

Equities

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

NOVAGALI PHARMA : announces its revenue for the first nine months of 2011	14/11/11	PU
NOVAGALI PHARMA : Revenue for the 3rd quarter of 2011	14/11/11	BU
NOVAGALI PHARMA : Santen Pharmaceutical Co., Ltd. Completes the Acquisition of a Controlling Interest in Novagali Pharma S.A.	11/10/11	BU
NOVAGALI PHARMA : Signing of an Acquisition of a Controlling Interest in Novagali Pharma S.A. by Santen Pharmaceutical Co., Ltd.	28/09/11	BU
NOVAGALI PHARMA : Catioprost Phase II positive results	08/09/11	PU

Novagali Pharma : retrait obligatoire le 6 janvier.	23/12/11
Novagali Pharma : l'OPAS ouvre le 2 décembre.	01/12/11
NOVAGALI PHARMA : Mise à disposition de la note en réponse relative à l'OPAS	01/12/11
Novagali Pharma : l'AMF déclare conforme le projet d'OPAS.	30/11/11
Novagali Pharma : hausse de 24% du CA trimestriel.	15/11/11

Sector

	1st Jan change	Capi.
MERCK KGAA	+4.30%	69.17B
KYOWA KIRIN CO. LTD.	+12.55%	9.06B
SK BIOPHARMACEUTICALS CO., LTD.	-12.75%	4.96B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+42.38%	4.47B
YUHAN CORPORATION	+5.23%	3.9B
INDIVIOR PLC	+21.52%	2.41B
BETTA PHARMACEUTICALS CO., LTD.	-19.05%	2.41B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-28.72%	2.23B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+11.13%	2.02B